Vanguard Capital Management
NRXS icon

Vanguard Capital Management’s Neuraxis NRXS Stock Holding History

Vanguard Capital Management’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
335,793
+109,926
+49% +$811K ﹤0.01% 3350
2026
Q1 		$1.67M Buy
+225,867
New +$1.24M ﹤0.01% 3420

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $167M AUM

Vanguard Capital Management's NRXS Position: Q2 2026 in Review

Vanguard Capital Management increased its Neuraxis (NRXS) stake by 49% in Q2 2026, buying an estimated $811K and bringing the position to 335,793 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3350.

Vanguard Capital Management first reported a position in NRXS in Q1 2026 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Vanguard Capital Management held 335,793 shares of Neuraxis worth $2.45M as of Q2 2026.
  • Vanguard Capital Management bought 109,926 Neuraxis shares in Q2 2026, an estimated $811K.
  • Neuraxis made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3350 holding.
  • Vanguard Capital Management first reported a position in Neuraxis in Q1 2026 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.